Vukasin Paunovich
Known title: Chief Technology OfficerCIK: 0001938690
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Doximity AI investment news highlights AMWL sector context. Recent coverage focuses on Doximity's ability to shrink its share count through AI investments. This is relevant to AMWL as it highlights broader trends in the healthcare technology sector. While no direct news was reported for American Well, the sector focus provides context for its current trading position.
Transaction History
| LFST | ▼ Sell | Open Market | 42,067 | $541K | 9/2/2026 | View on chart |
| LFST | ▼ Sell | Open Market | 44,394 | $482K | 8/10/2026 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 17,456 | $150K | 6/11/2026 | View on chart |
| LFST | ▲ Buy | Grant | 62,935 | $0 | 3/9/2026 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 18,541 | $128K | 3/9/2026 | View on chart |
| LFST | ▲ Buy | Grant | 86,331 | $0 | 3/5/2026 | View on chart |
| LFST | ▲ Buy | Grant | 178,571 | $0 | 6/11/2025 | View on chart |
| AMWL | ▼ Sell | Open Market | 444 | $3K | 1/2/2025 | View on chart |
| AMWL | ▼ Sell | Open Market | 3,213 | $30K | 12/2/2024 | View on chart |
| AMWL | ▼ Sell | Open Market | 398 | $4K | 10/1/2024 | View on chart |
| AMWL | ▼ Sell | Open Market | 3,141 | $25K | 9/3/2024 | View on chart |
| AMWL | ▼ Sell | Open Market | 7,956 | $2K | 7/1/2024 | View on chart |
| AMWL | ▼ Sell | Open Market | 62,810 | $26K | 6/3/2024 | View on chart |
| AMWL | ▼ Sell | Open Market | 31,712 | $34K | 3/1/2024 | View on chart |
| AMWL | ▼ Sell | Open Market | 251,323 | $274K | 2/23/2024 | View on chart |
| AMWL | ▲ Buy | Grant | 2,171,646 | $0 | 2/20/2024 | View on chart |
| AMWL | ▼ Sell | Open Market | 58,409 | $62K | 1/16/2024 | View on chart |
| AMWL | ▼ Sell | Open Market | 104,832 | $226K | 7/17/2023 | View on chart |
| AMWL | ▲ Buy | Grant | 274,378 | $0 | 3/1/2023 | View on chart |
| AMWL | ▲ Buy | Grant | 563,266 | $0 | 7/15/2022 | View on chart |
| AMWL | ▼ Sell | Tax Withholding | 68,051 | $289K | 7/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Keybanc Raises LifeStance Health Price Target to $15
Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.
Keybanc Raises LifeStance Health Price Target to $15. Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.